Trials / Withdrawn
WithdrawnNCT02164058
TandemHeart to Reduce Infarct Size (TRIS Trial)
A Randomized Controlled Multicenter Study on the Use of the TandemHeart to Reduce Infarct Size
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- CardiacAssist, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if a device known as the TandemHeart® System (TandemHeart) can help limit heart damage and reduce serious complications after a certain type of heart attack (acute ST elevation anterior wall myocardial infarction \[STEMI\]) by evaluating the use of the TandemHeart system prior to a procedure called percutaneous coronary intervention (PCI)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TandemHeart System | |
| PROCEDURE | Percutaneous coronary intervention |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-08-01
- Completion
- 2017-02-01
- First posted
- 2014-06-16
- Last updated
- 2015-12-04
Source: ClinicalTrials.gov record NCT02164058. Inclusion in this directory is not an endorsement.